#For patients
Written for adults considering a peptide as part of their health management.
What an IGF-1 result actually tells you
IGF-1 is a monitoring marker, not a dial to turn. What the number shows, what tesamorelin is licensed for, and why dose calls belong with a prescriber.
Can BPC-157 cause new visible veins?
BPC-157's angiogenesis data comes from cells, chick membranes and rats. No human study shows it grows new visible veins.
GLP-1 safety in neuroendocrine tumours
A 2026 European Journal of Endocrinology review weighs the evidence on GLP-1 receptor agonists like semaglutide in neuroendocrine neoplasms.
MASLD and cardiovascular risk explained
MASLD affects 38% of adults worldwide and heart disease kills more of them than liver failure. Where semaglutide fits, and what remains unproven.
Tirzepatide and a rash: one case report
A 2026 JAAD case report links a year of tirzepatide to a widespread rash that cleared when the drug stopped. One patient is not a risk rate.
Why weight loss stalls on tirzepatide
A weight loss plateau is the expected shape of the tirzepatide curve, not a failure. Here is what the trials show and where retatrutide really stands.
GLP-1 timing and pregnancy blood pressure
A 2026 meta-analysis of three cohorts found no significant link between GLP-1 use around conception and hypertensive disorders of pregnancy.
Can you drink alcohol on semaglutide?
Semaglutide's label carries no alcohol warning, but it flags gut, blood-sugar and pancreatitis effects that overlap with drinking. Here is the honest read.
Is semaglutide safe during pregnancy?
Semaglutide is not recommended in pregnancy. Here is what the Ozempic and Wegovy labels, the animal data, and the human exposure studies actually show.
Is retatrutide safe during pregnancy?
Retatrutide is investigational with no approved label. Every trial excluded pregnant women. Here is what the class-level evidence and trial record show.
Can you drink alcohol on retatrutide?
Retatrutide has no approved label, so there is no official alcohol guidance. Here is what the class literature and trial protocols report.
Is semaglutide safe during pregnancy?
Semaglutide is contraindicated during pregnancy. The FDA label cites adverse fetal outcomes in animal studies; all phase 3 programmes excluded pregnant women.